Carmat SA (EPA:ALCAR)

Market Cap	6.15M -87.3%
Revenue (ttm)	7.34M +91.4%
Net Income	-51.40M
EPS	-1.15
Shares Out	62.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	0.0990
Day's Range	n/a
52-Week Range	0.0850 - 0.9500
Beta	1.02
RSI	27.64
Earnings Date	Apr 8, 2026

About Carmat

Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 153
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALCAR

Financial Performance

In 2024, Carmat's revenue was 7.34 million, an increase of 91.40% compared to the previous year's 3.84 million. Losses were -51.40 million, -4.59% less than in 2023.